Identification of allosteric inhibitors of the ecto-5'-nucleotidase (CD73) targeting the dimer interface.
The ecto-5'-nucleotidase CD73 plays an important role in the production of immune-suppressive adenosine in tumor micro-environment, and has become a validated drug target in oncology. Indeed, the anticancer immune response involves extracellular ATP to block cell proliferation through T-cell ac...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS Computational Biology |
Online Access: | http://europepmc.org/articles/PMC5805337?pdf=render |
id |
doaj-906ca078de384f72a58cbc5f1b6b3fb1 |
---|---|
record_format |
Article |
spelling |
doaj-906ca078de384f72a58cbc5f1b6b3fb12020-11-25T01:11:55ZengPublic Library of Science (PLoS)PLoS Computational Biology1553-734X1553-73582018-01-01141e100594310.1371/journal.pcbi.1005943Identification of allosteric inhibitors of the ecto-5'-nucleotidase (CD73) targeting the dimer interface.Rahila RahimovaSimon FontanelCorinne LionneLars Peter JordheimSuzanne PeyrottesLaurent ChaloinThe ecto-5'-nucleotidase CD73 plays an important role in the production of immune-suppressive adenosine in tumor micro-environment, and has become a validated drug target in oncology. Indeed, the anticancer immune response involves extracellular ATP to block cell proliferation through T-cell activation. However, in the tumor micro-environment, two extracellular membrane-bound enzymes (CD39 and CD73) are overexpressed and hydrolyze efficiently ATP into AMP then further into immune-suppressive adenosine. To circumvent the impact of CD73-generated adenosine, we applied an original bioinformatics approach to identify new allosteric inhibitors targeting the dimerization interface of CD73, which should impair the large dynamic motions required for its enzymatic function. Several hit compounds issued from virtual screening campaigns showed a potent inhibition of recombinant CD73 with inhibition constants in the low micromolar range and exhibited a non-competitive inhibition mode. The structure-activity relationships studies indicated that several amino acid residues (D366, H456, K471, Y484 and E543 for polar interactions and G453-454, I455, H456, L475, V542 and G544 for hydrophobic contacts) located at the dimerization interface are involved in the tight binding of hit compounds and likely contributed for their inhibitory activity. Overall, the gathered information will guide the upcoming lead optimization phase that may lead to potent and selective CD73 inhibitors, able to restore the anticancer immune response.http://europepmc.org/articles/PMC5805337?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Rahila Rahimova Simon Fontanel Corinne Lionne Lars Peter Jordheim Suzanne Peyrottes Laurent Chaloin |
spellingShingle |
Rahila Rahimova Simon Fontanel Corinne Lionne Lars Peter Jordheim Suzanne Peyrottes Laurent Chaloin Identification of allosteric inhibitors of the ecto-5'-nucleotidase (CD73) targeting the dimer interface. PLoS Computational Biology |
author_facet |
Rahila Rahimova Simon Fontanel Corinne Lionne Lars Peter Jordheim Suzanne Peyrottes Laurent Chaloin |
author_sort |
Rahila Rahimova |
title |
Identification of allosteric inhibitors of the ecto-5'-nucleotidase (CD73) targeting the dimer interface. |
title_short |
Identification of allosteric inhibitors of the ecto-5'-nucleotidase (CD73) targeting the dimer interface. |
title_full |
Identification of allosteric inhibitors of the ecto-5'-nucleotidase (CD73) targeting the dimer interface. |
title_fullStr |
Identification of allosteric inhibitors of the ecto-5'-nucleotidase (CD73) targeting the dimer interface. |
title_full_unstemmed |
Identification of allosteric inhibitors of the ecto-5'-nucleotidase (CD73) targeting the dimer interface. |
title_sort |
identification of allosteric inhibitors of the ecto-5'-nucleotidase (cd73) targeting the dimer interface. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS Computational Biology |
issn |
1553-734X 1553-7358 |
publishDate |
2018-01-01 |
description |
The ecto-5'-nucleotidase CD73 plays an important role in the production of immune-suppressive adenosine in tumor micro-environment, and has become a validated drug target in oncology. Indeed, the anticancer immune response involves extracellular ATP to block cell proliferation through T-cell activation. However, in the tumor micro-environment, two extracellular membrane-bound enzymes (CD39 and CD73) are overexpressed and hydrolyze efficiently ATP into AMP then further into immune-suppressive adenosine. To circumvent the impact of CD73-generated adenosine, we applied an original bioinformatics approach to identify new allosteric inhibitors targeting the dimerization interface of CD73, which should impair the large dynamic motions required for its enzymatic function. Several hit compounds issued from virtual screening campaigns showed a potent inhibition of recombinant CD73 with inhibition constants in the low micromolar range and exhibited a non-competitive inhibition mode. The structure-activity relationships studies indicated that several amino acid residues (D366, H456, K471, Y484 and E543 for polar interactions and G453-454, I455, H456, L475, V542 and G544 for hydrophobic contacts) located at the dimerization interface are involved in the tight binding of hit compounds and likely contributed for their inhibitory activity. Overall, the gathered information will guide the upcoming lead optimization phase that may lead to potent and selective CD73 inhibitors, able to restore the anticancer immune response. |
url |
http://europepmc.org/articles/PMC5805337?pdf=render |
work_keys_str_mv |
AT rahilarahimova identificationofallostericinhibitorsoftheecto5nucleotidasecd73targetingthedimerinterface AT simonfontanel identificationofallostericinhibitorsoftheecto5nucleotidasecd73targetingthedimerinterface AT corinnelionne identificationofallostericinhibitorsoftheecto5nucleotidasecd73targetingthedimerinterface AT larspeterjordheim identificationofallostericinhibitorsoftheecto5nucleotidasecd73targetingthedimerinterface AT suzannepeyrottes identificationofallostericinhibitorsoftheecto5nucleotidasecd73targetingthedimerinterface AT laurentchaloin identificationofallostericinhibitorsoftheecto5nucleotidasecd73targetingthedimerinterface |
_version_ |
1725168826394345472 |